Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 2,873,280 | 2,892,539 | 0 | 0 | 0 |
| Cost of Goods | 797,760 | 744,633 | N/A | N/A | N/A |
| Gross Profit | 2,075,520 | 2,147,905 | N/A | N/A | N/A |
| Operating Expenses | 1,572,280 | 1,652,992 | 0 | 0 | 0 |
| Operating Income | 504,960 | 495,537 | N/A | N/A | N/A |
| Interest Expense | 6,720 | 20,698 | 0 | 0 | 0 |
| Other Income | 4,800 | 17,885 | 0 | 0 | 0 |
| Pre-tax Income | 503,040 | 492,724 | 0 | 0 | 0 |
| Income Tax | 175,680 | 141,287 | N/A | N/A | N/A |
| Net Income Continuous | 327,360 | 351,438 | N/A | N/A | N/A |
| Net Income | $327,360 | $351,438 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 0.15 | 0.16 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.15 | 0.16 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.15 | 0.16 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.15 | 0.16 | N/A | N/A | N/A |
| EBITDA(a) | $654,250 | $646,986 | $N/A | $N/A | $N/A |